Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome.

After adjustment for age, sex, baseline NIHSS score, and dose of rt-PA using a logistic regression model, the use of postthrombolytic AP therapy still exhibited a favorable trend, although not a statistically significant one ( Table 2 ), and there was no increase in mortality or in the mRS score 5 or 6 ratio.

also in 1,335 other papers